Rottapharm plans debut high yield bond as step towards IPO

05 Nov 2012

Rottapharm Madaus, an Italian-German pharmaceutical company, is looking to raise €400m in its debut bond issue. The planned notes are senior unsecured, have a 2019 maturity and are callable after three years.

JP Morgan is global coordinator, Banca Imi and Mediobanca joint bookrunners.

A roadshow started in London on Monday and will finish on Thursday, after visiting Frankfurt, Paris, Amsterdam and Milan.

With the proceeds of the Ba3/BB- rated notes and a new €100m bilateral loan facility, Rottapharm plans to repay ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial

Want to learn more? View subscription options